What are the top most costly diseases for USA? The alignment of burden of illness with prevention and screening expenditures
Guvenc Kockaya, Albert Wertheimer
DOI: 10.4236/health.2010.210172   PDF    HTML     8,300 Downloads   17,147 Views   Citations


Background: It was the intention of the authors to generate a list of the top diseases responsible for the greatest financial expense in the United States. This listing would then inform policymakers as to the highest priority target conditions. With such information available, funding for the NIH could be accomplished based upon factual criteria rather than political clout or uninformed consensus. Method: The first step was a literature review to explore articles and reports which were published about the cost of illness (COI) up to December 2009. Therefore the source of the data used in this investigation was obtained from this retrospective search approach. Results: With reference to total cost for disease, first was HCVD with 475.3 billion US dollars, followed by alcohol abuse and substance at 300.6 billion US dollars, digestive diseases at 259.6 billion US dollars, cancer at 239.5 billion US dollars and mental disease at 216,6 billion US dollars. Conclusion: As has been seen, the total societal costs of the diseases do not synch with the degree of attention paid to these various disease states. Several of the diseases have very powerful and vocal support organizations that encourage attention and clinical research support. On the other hand we hear very little about efforts against allergic rhinitis or infectious and parasitic diseases.

Share and Cite:

Kockaya, G. and Wertheimer, A. (2010) What are the top most costly diseases for USA? The alignment of burden of illness with prevention and screening expenditures. Health, 2, 1174-1178. doi: 10.4236/health.2010.210172.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Kirschtein, R. (2000) Disease-Specific Estimates of Direct and Indirect Costs of Illness and Department of Health and Human Services NIH Support, Washington DC. http://ospp.od.nih.gov/ecostudies/COIreportweb.htm
[2] Bloom, B.S., Bruno, D.J., Maman, D.Y. and Jayadevappa, R. (2001) Usefulness of US cost-of-?llness studies. Healthcare Decision Making Pharmacoeco- nomics, 19(2), 207-213.
[3] Alzheimer’s Association (2009) Alzheimer’s disease facts and figures. Alzheimers Dement, 5(3), 234-270.
[4] Clabaugh, G. and Ward, M.M. (2008) Cost-of-illness studies in the United States: A systematic review of methodologies used for direct cost value. Health, 11(1), 13-21.
[5] A Report from the American Heart Association Statistics Committee and stroke statistics subcommittee heart disease and stroke statistics (2009) Update Circulation. 119, e21-e181.
[6] National Institutes of Health National Heart, Lung and Blood Institute Fact Book Fiscal Year, US Department of Health and Human Services, Washington, DC., 2008. www.nhlbi.nih.gov/about/factbook/FactBookFinal. pdf
[7] Lipsy, R.J. and Pharm, D. (2008) BCPS, FASHP assessing the short-term and long-term burden of ?llness in Cervical cancer. American Journal of Managed Care, 14, S177-S184.
[8] Greenberg, P.E. and Kessler, R.C. (2003) The economic burden of depression in the United States: How did it change between 1990 and 2000? Journal of Clinical Psychiatry, 64(12), 1465-1475.
[9] Wu, E.Q., Birnbaum, H.G., Shi, L., Ball, D.E., Kessler, R.C., Moulis, M. and Aggarwal, J. (2005) The economic burden of Schizophrenia in the United States in 2002, Journal of Clinical Psychiatry, 66(9), 1122-1129.
[10] Fiore, M.C., Jaén, C.R., Baker, T.B., et al. (2009) Treating tobacco use and dependence: 2008 date. quick reference guide for clinicians. Rockville, Department of Health and Human Services. Public Health Service. http://www.ahrq.gov/clinic/tobacco/tobaqrg.pdf
[11] (2008) American Diabetes Association Economic Costs of Diabetes in the U.S. in 2007. Diabetes Care, 31, 596-615.
[12] (2004) National heart, lung, and blood ?nstitute. Mor- bidity and mortality: 2004 chartbook on cardiovascular, lung, and blood diseases. US Department of Health and Human Services, Washington, DC.
[13] Huse, D.M., Schulman, K., Orsini, L., Castelli-Haley, J., Kennedy, S. and Lenhart, G. (2005) Burden of illness in Parkinson’s disease. Movement Disorders, 20, 1449- 1454.
[14] Henry, X. and Hu, M.D. (1999) Burden of Migraine in the United States. Archives of Internal Medicine, 159, 813-818.
[15] Yoon, D., Frick, K.D., Carr, D.A. and Austin, J.K. (2009) Economic impact of epilepsy in the United States. Epilepsia, 50(10), 2186-2191.
[16] Yelin, E., Murphy, L., Cisternas, M.G., Foreman, A.J., Pasta, D.J., Helmick, C.G. (2007) Medical care ex- penditures and earnings loses among persons with arthritis and other rheumatic condition in 2003. Arthritis and Rheumatism, 56(5), 1397-1407.
[17] Onukwugha, E. and Zuckerman, I.H. (2009) The total economic burden of overactive bladder in the United States: A disease-specific approach. American Journal of Managed Care, 15(4 Suppl.), S90-S97.
[18] Fendrick, A.M. and Monto, A.S. (2003) The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch Intern Med., 163(4), 487-494.
[19] Hutchinson, A.B., Farnham, P.G., Dean, H.D., Ekwueme, D.U., del Rio, C., Kamimoto, L., et al. (2006) The economic burden of HIV in the United States in the era of highly active antiretroviral therapy: Evidence of continuing racial and ethnic differences. Journal of Acquired Immune Deficiency Syndromes, 43(4), 451-457.
[20] Molinari, N.A. and Ortega-Sanchez, I.R. (2007) The annual impact of seasonal influenza in the US: Measuring disease burden and costs. Vaccine, 25(27), 5086-5096.
[21] Malone, D.C., Lawson, K.A., Smith, D.H., Arrighi, H.M., Battista, C. (1997) A cost of illness study of allergic rhinitis in the United States. Journal of Allergy and Clinical Immunology, 99(1 Pt 1), 22-27.
[22] Chesson, H.W., Blandford, J.M., Gift, T.L., Tao, G. and Irwin, K.L. (2004) The estimated direct medical cost of sexually transmitted diseases among American youth, 2000 perspectives on sexual and reproductive health. 36 (1), 11-19.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.